Colin Kerr
EuroTimes articles by Colin Kerr
-
Strengthening ties
Friday, March 1, 2019Winter Meeting in conjunction with Hellenic Society of Intraocular Implant and Refractive Surgery was a major success with more than 1,870 delegates
-
Next-generation monofocal IOL
Friday, March 1, 2019Johnson & Johnson Vision has announced the launch of its TECNIS Eyhance IOL in Europe
-
40 years of service
Friday, March 1, 2019Oculus director Rainer Kirchhübel celebrates 40th work anniversary
-
CE marking
Friday, March 1, 2019Heidelberg Engineering announces CE marking of SPECTRALIS High Magnification Module
-
Advancing knowledge
Saturday, February 16, 2019Konstantina Koufala, HSIOIRS President, reflects on the Society’s distinguished history
-
ESCRS Education Forum Lunch Symposia
Friday, February 15, 2019Today Friday, February 15, two exciting lunchtime ESCRS Education Forum symposia will be taking place.
-
23rd ESCRS Winter Meeting convenes
Friday, February 15, 2019The 23rd ESCRS Winter Meeting convenes from Friday 15 February to Sunday February 17 in Athens, Greece.
-
Expanding Portfolio
Friday, February 1, 2019Oculis SA has entered into an agreement to license a novel topical anti-TNF alpha antibody from Novartis. The compound, LME 636, is based on a proprietary single-chain antibody fragment technology specifically designed for topical delivery. Efficacy and safety were evaluated in three clinical trials. Dr Riad Sherif, Oculis CEO, said: “This agreement is part of […]
-
Diagnosing and Treating Ocular Surface Disease in Surgical Patients
Friday, February 1, 2019In this supplement, published by EuroTimes in association with the ESCRS/EuCornea Education Forum, we learn about the diagnostics and management of ocular surface disease in surgical patients. The supplement includes articles by José L Güell, Spain; Béatrice Cochener-Lamard, France; Carina Koppen, Belgium; José M. Benitez-del-Castillo, Spain; and Jesper Hjortdal, Denmark. The supplement is supported by […]
-
Technology solutions
Friday, February 1, 2019Carl Zeiss Meditec has completed the acquisition of ianTECH, a privately held company focused on technology solutions for micro-interventional cataract surgery headquartered in Reno, Nevada. “Cataract surgery has been dependent on phaco technology for over 50 years. ZEISS believes that the market needs a fresh, innovative approach in the field of phaco. ianTECH’s surgical technology […]
